Morgan Stanley executive chairman James Gorman will step down at year end-March 2024-www.financetom.com

Morgan Stanley executive chairman James Gorman will step down at year end

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Morgan Stanley executive chairman James Gorman will step down at year end

May 23, 2024 6:53 AM

NEW YORK (Reuters) -Morgan Stanley's ( MS ) executive chairman James Gorman will step down on Dec. 31, he told the bank's annual shareholder meeting.

The former CEO cited the "successful transition" of his successor Ted Pick into the top job at the start of this year.

Gorman's compensation in 2023, his last year as CEO, rose 17% to $37 million.

Gorman spent 14 years at the helm and is credited with transforming the bank into a wealth management powerhouse. He also orchestrated a succession plan in which Pick took the reins at the same time as retaining the two other CEO candidates, executives Andy Saperstein and Dan Simkowitz, a rarity on Wall Street.

(Reporting by Nupur Anand in New York and Manya Saini in Bengaluru)

Previous page： Form 8.3 Next page： BioNTech says collaboration with Pfizer remains unchanged

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Form 8.3

Nov 13, 2025

LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...

BioNTech says collaboration with Pfizer remains unchanged

Nov 13, 2025

FRANKFURT (Reuters) -BioNTech said on Thursday that its collaboration with Pfizer ( PFE ) has not changed, when asked to comment on a report that Pfizer ( PFE ) is looking to sell its stake in the German biotech firm. We continue to have a close and strong collaboration, a spokesperson said in a statement, adding that BioNTech would not...

Tidewater Renewables Narrows Q3 Loss Despite Lower Revenue

Nov 13, 2025

08:15 AM EST, 11/13/2025 (MT Newswires) -- Tidewater Renewables ( TDWRF ) on Thursday reported a narrowed net loss in the third quarter despite a fall in revenue. For the three months ended Sept. 30, net loss was $1.0 million or $0.03 loss per diluted share compared with a net loss of $367.1 million or $10.46 loss per diluted share,...

First Mining Gold's Q3 Loss Widens as Project Work Continues

Nov 13, 2025

08:17 AM EST, 11/13/2025 (MT Newswires) -- First Mining Gold ( FFMGF ) said Thursday that its net loss widened in the third quarter. The company reported a net loss and comprehensive loss of C$21.5 million, or a loss of $0.02 per share, in the three months ended Sept. 30, compared to a year-ago loss of $5.7 million, or a...